EP Patent

EP1461336B1 — 1-alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists

Assigned to Chiesi Farmaceutici SpA · Expires 2013-05-22 · 13y expired

What this patent protects

Patent listed against Arnuity Ellipta.

Drugs covered by this patent

Patent Metadata

Patent number
EP1461336B1
Jurisdiction
EP
Classification
—
Expires
2013-05-22
Drug substance claim
No
Drug product claim
No
Assignee
Chiesi Farmaceutici SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.